Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02795455 · ClinicalTrials.gov registry record · NA

Reward Systems and Food Avoidance in Eating Disorders

A NA study of Anorexia Nervosa and Low Weight Eating Disorders, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02795455 is a NA study of Anorexia Nervosa and Low Weight Eating Disorders that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 90 participants, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02795455, a NA study of Anorexia Nervosa and Low Weight Eating Disorders, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The researchers plan to explore brain networks involved in emotion processing and learning using a brain scan and test meals. One core feature of Anorexia Nervosa (AN) is eating a small number of high-calorie or high-fat foods. By studying why individuals with AN are disgusted by food or other eating situations, the researchers will be able to understand more about the neurobiological pathways that lead to restricting food intake and food avoidance. This study also aims to find whether one of two short-term interventions (Interoceptive Exposure (IE); Family-Based Therapy (FBT)) affects connections in the brain and if the treatments affect food avoidance. IE is an intervention that helps reduce anxiety about eating. FBT is an intervention that motivates patients to eat through working with family to increase the value of eating and decrease the value of avoiding foods.

Interventions

  • BEHAVIORAL Interoceptive Exposure (IE)
  • BEHAVIORAL Family Based Therapy-Weight Gain Control (FBT-WG)
  • DIETARY_SUPPLEMENT meal replacement shake

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2016-11
Est. Completion 2021-07-29
Phase NA

What the Registry Record Tells You About NCT02795455

The ClinicalTrials.gov registry entry for NCT02795455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (91% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 3 interventions - of which Interoceptive Exposure (IE) is the first listed.

NCT02795455 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02795455 about?

NCT02795455 is a clinical study titled "Reward Systems and Food Avoidance in Eating Disorders". The researchers plan to explore brain networks involved in emotion processing and learning using a brain scan and test meals. One core feature of Anorexia Nervosa (AN) is eating a small number of high-calorie or high-fat foods. By studying why individuals with AN are disgusted by food or other eatin...

What is the current status of trial NCT02795455?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-11. Estimated completion is 2021-07-29.

What conditions does trial NCT02795455 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Low Weight Eating Disorders.

What interventions are being tested in trial NCT02795455?

The interventions under investigation include: Interoceptive Exposure (IE) (BEHAVIORAL), Family Based Therapy-Weight Gain Control (FBT-WG) (BEHAVIORAL), meal replacement shake (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02795455?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02795455 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.